Nav: Home

In blacks with Alzheimer's gene, higher education may be protective

October 30, 2019

NEW YORK, NY (Oct. 30, 2019)--Education may erase the risk of cognitive decline associated with the APOE e4 gene--the biggest genetic risk factor for late-onset Alzheimer's disease--in older non-Hispanic black people, according to a new study by researchers at Columbia University Vagelos College of Physicians and Surgeons.

The study was published online (pre-press) in the Journal of Alzheimer's Disease.

"There's frustratingly little we can do to lessen the risk of Alzheimer's disease, but education appears to be one of the few interventions that we know works," says first author Jet M.J. Vonk, PhD, a postdoctoral research scientist in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University Vagelos College of Physicians and Surgeons.

Does Education Preserve Cognitive Ability for All Older Adults?

Several studies, mainly in non-Hispanic white people, have shown that the higher one's level of education, the lower one's risk of dementia--even among those who are genetically at higher risk for Alzheimer's, such as carriers of the APOE e4 gene.

Even before Alzheimer's is diagnosed, older individuals with the APOE e4 gene have, on average, poorer cognitive function than non-carriers.

But none of these studies had focused on non-Hispanic blacks, a population with fewer years of education and higher rates of APOE e4 and dementia than non-Hispanic whites.

The researchers looked at 849 non-Hispanic Blacks (average age of 69 years) of various educational levels who were enrolled in a multicenter study investigating genetic and environmental factors that influence Alzheimer's onset. None of the participants had dementia, though about 38% carried the APOE e4 gene.

The participants underwent comprehensive neuropsychological testing to evaluate memory and cognition.

Education After High School Provides a Safeguard

Overall, among individuals with more than a high school degree, APOE e4 carriers performed just as well on two key memory tests as non-carriers, an effect that was particularly pronounced in women. "This suggests that education can buffer the effects of the APOE e4 gene on episodic memory retention and working memory, which are usually the first types of memory to be affected in people with Alzheimer's," says Vonk.

The findings do not have any implications for clinical practice. "The important point is that education is a modifiable risk factor for cognitive decline. It's something that we can target with public policies that increase access to higher education," says Vonk.

The current study focused on the effects of formal education through high school and college. "We also hope to examine which other social and environmental factors later in life, from your 20s through your 60s, may help buffer cognitive decline associated with the APOE e4 gene in this population," Vonk says.
More Information

Jet Vonk, PhD, is also a visiting scholar at the Julius Center for Health Sciences and Primary Care at Utrecht University in the Netherlands.

The study is titled, "Education Moderates the Relation Between APOE e4 and Memory in Nondemented Non-Hispanic Black Older Adults," and will be published in Journal of Alzheimer's Disease on November 12, 2019 72(2). The other contributors are: Miguel Arce Rentería (Columbia University Irving Medical Center, New York ,NY), Valerie M. Medina (CUIMC), Margaret A. Pericak-Vance (University of Miami, Miami, FL), Goldie S. Byrd (North Carolina Agricultural and Technical State University, Dean, College of Arts and Sciences, Greensboro, NC), Jonathan Haines (Vanderbilt University, Nashville, TN), Adam M. Brickman (CUIMC), and Jennifer J. Manly (CUIMC).

View the article (pre-press) here:

The research was supported by grants from the National Institutes of Health (R01 AG028786) and by an Alzheimer Nederland fellowship.

The authors reported the following competing interests: Dr. Brickman has consulted for Keystone Heart, Regeneron Pharmaceuticals, and Cognition Therapeutics; has shares in Mars Holding Limited (a shareholder of Venus Medtech, Inc.), and has a patent (US patent number 9867566) and a patent pending (US publication number 20180228422) for methods and systems for evaluating age-related memory loss.

Columbia University Irving Medical Center

Related Memory Articles:

Memory boost with just one look
HRL Laboratories, LLC, researchers have published results showing that targeted transcranial electrical stimulation during slow-wave sleep can improve metamemories of specific episodes by 20% after only one viewing of the episode, compared to controls.
VR is not suited to visual memory?!
Toyohashi university of technology researcher and a research team at Tokyo Denki University have found that virtual reality (VR) may interfere with visual memory.
The genetic signature of memory
Despite their importance in memory, the human cortex and subcortex display a distinct collection of 'gene signatures.' The work recently published in eNeuro increases our understanding of how the brain creates memories and identifies potential genes for further investigation.
How long does memory last? For shape memory alloys, the longer the better
Scientists captured live action details of the phase transitions of shape memory alloys, giving them a better idea how to improve their properties for applications.
A NEAT discovery about memory
UAB researchers say over expression of NEAT1, an noncoding RNA, appears to diminish the ability of older brains to form memories.
Molecular memory can be used to increase the memory capacity of hard disks
Researchers at the University of Jyväskylä have taken part in an international British-Finnish-Chinese collaboration where the first molecule capable of remembering the direction of a magnetic above liquid nitrogen temperatures has been prepared and characterized.
Memory transferred between snails
Memories can be transferred between organisms by extracting ribonucleic acid (RNA) from a trained animal and injecting it into an untrained animal, as demonstrated in a study of sea snails published in eNeuro.
An immunological memory in the brain
Inflammatory reactions can change the brain's immune cells in the long term -- meaning that these cells have an 'immunological memory.' This memory may influence the progression of neurological disorders that occur later in life, and is therefore a previously unknown factor that could influence the severity of these diseases.
Anxiety can help your memory
Anxiety can help people to remember things, a study from the University of Waterloo has found.
Pores with a memory
Whether for separation processes, photovoltaics, catalysis, or electronics, porous polymer membranes are needed in many fields.
More Memory News and Memory Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at